Abiogen Pharma S.p.A.

Abiogen Pharma is a prominent Italian pharmaceutical company founded in 1997 by Massimo Di Martino. The company focuses on the research, development, manufacturing, and commercialization of innovative solutions, with a strong historical expertise in bone metabolism, pain management, respiratory, diabetes, and dermatological areas. It operates as a family-owned business and maintains a significant international presence, exporting to over 40 countries. The company integrates R&D, production, and marketing, operating a state-of-the-art manufacturing facility in Pisa, Italy, which also provides contract manufacturing and development services (CDMO) to third-party partners. Abiogen has pursued an internationalization strategy through strategic acquisitions, including the German company Altamedics and the Swiss company EffRx Pharmaceuticals, to strengthen its portfolio in rare diseases and musculoskeletal pathologies.